Division of Federal Employees' Compensation (DFEC)
Schedule II Drug Program Changes for FECA
On May 3, 2011, The Department of Labor (DOL) implemented a new policy for processing Schedule II drugs for claimants who are identified as recipients under the Federal Employees Compensation Act (FECA) Program. Patients who do not have a diagnosis of cancer as an accepted work-related medical condition and have not received a fentanyl prescription in the past six months will no longer be able to receive fentanyl prescriptions, except for Duragesic. Patients with a diagnosis of cancer as an accepted work-related medical condition will continue to be able to receive Schedule II medications, including fentanyl products, in the same manner as today. All Schedule 2 prescriptions continue to be subject to early refill limitation and days' supply limitations. This includes the requirement that a claimant use 75% of the previous fill before being allowed to receive another fill of the same Schedule 2 medication and that a Schedule II fill be limited to 30 days. Please contact the PBM call center @ 866-664-5581 with any questions about these changes.